Refractory Diabetic Macular Edema Clinical Trial
Official title:
The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema
after advent of RD photoreceptor degeneration Occurred. This process appears as a incredible
and progressive event that will not stop till reattachment of RPE and neurosensory retina
happened .
Process of degeneration begins from first hours of RD establishment Neuroprotection of
photoreceptor following RD is a novel and debatable discussion encountered in recent years .
How to stop this phenomena and neuroprotective agent role in this issue are a new interest of
researches.
In the study investigators are planning to perform a clinical trial to demonstrate the
minocycline neuroprotective effect in a double blind design as this impact has been
implicated previously in a animal study.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04005430 -
A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema
|
Phase 1 |